369 related articles for article (PubMed ID: 8610052)
1. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
Ittmann MM
Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer.
Gao X; Zacharek A; Salkowski A; Grignon DJ; Sakr W; Porter AT; Honn KV
Cancer Res; 1995 Mar; 55(5):1002-5. PubMed ID: 7866981
[TBL] [Abstract][Full Text] [Related]
5. P53 mutations and loss of heterozygosity on chromosomes 8p, 16q, 17p, and 18q are confined to advanced prostate cancer.
Massenkeil G; Oberhuber H; Hailemariam S; Sulser T; Diener PA; Bannwart F; Schäfer R; Schwarte-Waldhoff I
Anticancer Res; 1994; 14(6B):2785-90. PubMed ID: 7872719
[TBL] [Abstract][Full Text] [Related]
6. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
[TBL] [Abstract][Full Text] [Related]
7. Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer.
Gao X; Zacharek A; Grignon DJ; Sakr W; Powell IJ; Porter AT; Honn KV
Oncogene; 1995 Oct; 11(7):1241-7. PubMed ID: 7478543
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms.
Honjo N; Gunduz M; Fukushima K; Cengiz B; Beder LB; Gunduz E; Nagatsuka H; Xiao J; Shimizu K; Nishizaki K
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):119-25. PubMed ID: 17599578
[TBL] [Abstract][Full Text] [Related]
10. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.
Cairns P; Okami K; Halachmi S; Halachmi N; Esteller M; Herman JG; Jen J; Isaacs WB; Bova GS; Sidransky D
Cancer Res; 1997 Nov; 57(22):4997-5000. PubMed ID: 9371490
[TBL] [Abstract][Full Text] [Related]
11. Deletion at chromosome arms 6q16-22 and 10q22.3-23.1 associated with initiation of prostate cancer.
Lu T; Hano H
Prostate Cancer Prostatic Dis; 2008; 11(4):357-61. PubMed ID: 18227855
[TBL] [Abstract][Full Text] [Related]
12. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
13. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21.
Vocke CD; Pozzatti RO; Bostwick DG; Florence CD; Jennings SB; Strup SE; Duray PH; Liotta LA; Emmert-Buck MR; Linehan WM
Cancer Res; 1996 May; 56(10):2411-6. PubMed ID: 8625320
[TBL] [Abstract][Full Text] [Related]
14. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
[TBL] [Abstract][Full Text] [Related]
15. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.
Fiedler U; Ehlers W; Meye A; Füssel S; Faller G; Schmidt U; Wirth MP
Anticancer Res; 2001; 21(4A):2341-50. PubMed ID: 11724291
[TBL] [Abstract][Full Text] [Related]
16. Detection of 17p loss in gastric carcinoma using polymerase chain reaction.
Kim CJ; Kim WH; Kim CW; Lee JB; Lee CK; Kim YL
Lab Invest; 1995 Feb; 72(2):232-6. PubMed ID: 7853854
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetic changes associated with ovarian cancer.
Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
[TBL] [Abstract][Full Text] [Related]
19. Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer.
Trybus TM; Burgess AC; Wojno KJ; Glover TW; Macoska JA
Cancer Res; 1996 May; 56(10):2263-7. PubMed ID: 8625295
[TBL] [Abstract][Full Text] [Related]
20. Loss of the chromosomal region 10q23-25 in prostate cancer.
Gray IC; Phillips SM; Lee SJ; Neoptolemos JP; Weissenbach J; Spurr NK
Cancer Res; 1995 Nov; 55(21):4800-3. PubMed ID: 7585509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
